YS Biopharma Co., Ltd. (YS)
NASDAQ: YS · IEX Real-Time Price · USD
0.800
+0.005 (0.63%)
At close: Apr 26, 2024, 4:00 PM
0.820
+0.020 (2.45%)
After-hours: Apr 26, 2024, 5:13 PM EDT
YS Biopharma Co. Market Cap
YS Biopharma Co. has a market cap or net worth of $150.66 million as of April 26, 2024. Its market cap has decreased by -6.42% in one year.
Market Cap
150.66M
Enterprise Value
196.96M
1-Year Change
-6.42%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since June 9, 2021, YS Biopharma Co.'s market cap has decreased from $257.50M to $150.66M, a decrease of -41.49%. That is a compound annual growth rate of -16.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 74.00M | -1.86% |
Apr 24, 2024 | 75.40M | -0.13% |
Apr 23, 2024 | 75.50M | 9.42% |
Apr 22, 2024 | 69.00M | 2.22% |
Apr 19, 2024 | 67.50M | -15.20% |
Apr 18, 2024 | 79.60M | -8.61% |
Apr 17, 2024 | 87.10M | 9.56% |
Apr 16, 2024 | 79.50M | -3.99% |
Apr 15, 2024 | 82.80M | 3.50% |
Apr 12, 2024 | 80.00M | -0.62% |
Apr 11, 2024 | 80.50M | -3.94% |
Apr 10, 2024 | 83.80M | 5.94% |
Apr 9, 2024 | 79.10M | -3.42% |
Apr 8, 2024 | 81.90M | -0.24% |
Apr 5, 2024 | 82.10M | -1.79% |
Apr 4, 2024 | 83.60M | 6.63% |
Apr 3, 2024 | 78.40M | 12.48% |
Apr 2, 2024 | 69.70M | 3.26% |
Apr 1, 2024 | 67.50M | 0.75% |
Mar 28, 2024 | 67.00M | 1.36% |
Mar 27, 2024 | 66.10M | 12.80% |
Mar 26, 2024 | 58.60M | -3.14% |
Mar 25, 2024 | 60.50M | 3.24% |
Mar 22, 2024 | 58.60M | 0.51% |
Mar 21, 2024 | 58.30M | -0.51% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CervoMed | 154.51M |
Inogen | 153.76M |
Butterfly Network | 150.74M |
I-Mab | 150.63M |
Scilex Holding Company | 149.59M |
Adicet Bio | 144.57M |
ClearPoint Neuro | 144.32M |
P3 Health Partners | 143.74M |